Xiaoling Zhang

4.2k total citations · 1 hit paper
54 papers, 2.0k citations indexed

About

Xiaoling Zhang is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Xiaoling Zhang has authored 54 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Genetics and 11 papers in Physiology. Recurrent topics in Xiaoling Zhang's work include Genetic Associations and Epidemiology (11 papers), Alzheimer's disease research and treatments (11 papers) and Dementia and Cognitive Impairment Research (6 papers). Xiaoling Zhang is often cited by papers focused on Genetic Associations and Epidemiology (11 papers), Alzheimer's disease research and treatments (11 papers) and Dementia and Cognitive Impairment Research (6 papers). Xiaoling Zhang collaborates with scholars based in United States, China and United Kingdom. Xiaoling Zhang's co-authors include Fang Zhu, Lisa M. Guay‐Woodford, Louis H. Wetzel, Kyongtae T. Bae, William M. Bennett, Bernard F. King, J. Philip Miller, Peter C. Harris, Deborah A. Baumgarten and Vicente E. Torres and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Neurology.

In The Last Decade

Xiaoling Zhang

52 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Volume Progression in Polycystic Kidney Disease

2006 540 citations Jared J. Grantham, Vicente E. Torres et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Xiaoling Zhang

Since Specialization

Citations

This map shows the geographic impact of Xiaoling Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Zhang more than expected).

Fields of papers citing papers by Xiaoling Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Zhang. The network helps show where Xiaoling Zhang may publish in the future.

Co-authorship network of co-authors of Xiaoling Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Zhang. A scholar is included among the top collaborators of Xiaoling Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Zhang. Xiaoling Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypertension and burden of myocardial infarction in China: risk factors, gender differences and temporal trends from a National Chronic Disease Surveillance study (2021–2023) 2025 ·Blood Pressure ·Xiaoling Zhang, Dan Huang, Jianxun Zhao, Jinhui Wu	1
2	Pro-healing impact of liraglutide on skin wounds in normoglycemic mice 2025 ·International Immunopharmacology ·Yue Han, Xiaoling Zhang, (unknown), Song Gong, Shiying Shao	2
3	Multi‐ancestry whole genome sequencing analysis of 36,361 individuals from the Alzheimer’s Disease Sequencing Project (ADSP) 2024 ·Alzheimer s & Dementia ·Brian W. Kunkle, John Farrell, (unknown), (unknown), Congcong Zhu, Kara L. Hamilton‐Nelson, (unknown), Xiaoling Zhang, (unknown), Jiemin Yang, Adam C. Naj, Eden R. Martin, Anita L. DeStefano, Seung Hoan Choi, (unknown)	1
4	Improved and Interpretable Prediction of Cytochrome P450-Mediated Metabolism by Molecule-Level Graph Modeling and Subgraph Information Bottlenecks 2024 ·Journal of Chemical Information and Modeling ·(unknown), (unknown), (unknown), Xiaoling Zhang, Hua Wang	0
5	Identification of circRNAs linked to Alzheimer's disease and related dementias 2023 ·Alzheimer s & Dementia ·(unknown), (unknown), (unknown), (unknown), Thor D. Stein, Lindsay A. Farrer, Benjamin Wolozin, Xiaoling Zhang	29
6	Testing the knowledge of Alzheimer's disease via an intervention study among community health service center staff in Jiaxing, China 2023 ·Frontiers in Public Health ·Weiwei Ma, Li Zhu, (unknown), (unknown), (unknown), (unknown), Xiaoling Zhang	7
7	Different loneliness types, cognitive function, and brain structure in midlife: Findings from the Framingham Heart Study 2022 ·EClinicalMedicine ·Qiushan Tao, Samia C. Akhter‐Khan, Ting Fang Alvin Ang, Charles DeCarli, Michael L. Alosco, Jesse Mez, Ronald Killiany, Sherral Devine, Ami Rokach, (unknown), Xiaoling Zhang, Kathryn L. Lunetta, David C. Steffens, Lindsay A. Farrer, Douglas N. Greve, Rhoda Au, Wei Qiao Qiu	21
8	Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities 2022 ·Pharmacology & Therapeutics ·Shiying Shao, Xiaoling Zhang, Qinqin Xu, Ruping Pan, Yong Chen	24
9	Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue 2021 ·Translational Psychiatry ·Devanshi Patel, Xiaoling Zhang, John J. Farrell, Jaeyoon Chung, Thor D. Stein, Kathryn L. Lunetta, Lindsay A. Farrer	34
10	CpG‐related SNPs in the MS4A region have a dose‐dependent effect on risk of late–onset Alzheimer disease 2019 ·Aging Cell ·Yiyi Ma, Gyungah Jun, Jaeyoon Chung, Xiaoling Zhang, Brian W. Kunkle, Adam C. Naj, Charles C. White, David A. Bennett, Philip L. De Jager, Richard Mayeux, Jonathan L. Haines, Margaret A. Pericak‐Vance, Gerard D. Schellenberg, Lindsay A. Farrer, Kathryn L. Lunetta	10
11	Acacetin protects against cerebral ischemia-reperfusion injury via the NLRP3 signaling pathway 2019 ·Neural Regeneration Research ·Yi Zhu, (unknown), (unknown), Huiqin Wang, (unknown), (unknown), Weidong Wu, Xiaoling Zhang, Zhi Ma, Yanjun Zhang, Hui Zhang	57
12	Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder 2018 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Hamid M. Abdolmaleky, Adam C. Gower, Chen Khuan Wong, (unknown), Xiaoling Zhang, Arunthathi Thiagalingam, Rahim Shafa, V. Sivaraman, Jin‐Rong Zhou, Sam Thiagalingam	29
13	c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification 2018 ·PMC ·Mark W. Zimmerman, Yu Liu, Shuning He, Adam D. Durbin, Brian J. Abraham, John M. Easton, Ying Shao, Beisi Xu, Shizhen Zhu, Xiaoling Zhang, Zhaodong Li, Nina Weichert‐Leahey, Richard A. Young, Jinghui Zhang, A. Thomas Look	2
14	Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease 2018 ·Alzheimer s Research & Therapy ·Jaeyoon Chung, Xiaoling Zhang, Mariet Allen, Xue Wang, Yiyi Ma, Gary W. Beecham, Thomas J. Montine, Steven G. Younkin, Dennis W. Dickson, Todd E. Golde, Nathan D. Price, Nilüfer Ertekin‐Taner, Kathryn L. Lunetta, Jesse Mez, Richard Mayeux, Jonathan L. Haines, Margaret A. Pericak‐Vance, Gerard D. Schellenberg, Gyungah Jun, Lindsay A. Farrer	21
15	MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification 2017 ·Cancer Discovery ·Mark W. Zimmerman, Yu Liu, Shuning He, Adam D. Durbin, Brian J. Abraham, John Easton, Ying Shao, Beisi Xu, Shizhen Zhu, Xiaoling Zhang, Zhaodong Li, Nina Weichert‐Leahey, Richard A. Young, Jinghui Zhang, A. Thomas Look	147
16	Differences in plasma metabolomics between sows feddl-methionine and its hydroxy analogue reveal a strong association of milk composition and neonatal growth with maternal methionine nutrition 2015 ·British Journal Of Nutrition ·Xiaoling Zhang, (unknown), Guangmang Liu, (unknown), Yves Mercier, Caimei Wu, (unknown), Lianqiang Che, Yan Lin, Shengyu Xu, Gang Tian, Daiwen Chen, De Wu, Zhengfeng Fang	16
17	Comparison of Nasal Epithelial Smoking‐Induced Gene Expression on Affymetrix Exon 1.0 and Gene 1.0 ST Arrays 2013 ·The Scientific World JOURNAL ·Xiaoling Zhang, Marc E. Lenburg, Avrum Spira	2
18	Oxa-Michael Addition Catalyzed by Amide-Based Acidic Ionic Liquids 2011 ·CHINESE JOURNAL OF CATALYSIS (CHINESE VERSION) ·Xiaoling Zhang	1
19	Volume Progression in Polycystic Kidney Disease breakdown → 2006 ·New England Journal of Medicine ·Jared J. Grantham, Vicente E. Torres, Arlene B. Chapman, Lisa M. Guay‐Woodford, Kyongtae T. Bae, Bernard F. King, Louis H. Wetzel, Deborah A. Baumgarten, Phillip J. Kenney, Peter C. Harris, Saulo Klahr, William M. Bennett, (unknown), Catherine M. Meyers, Xiaoling Zhang, Fang Zhu, J. Philip Miller	540
20	In vitro culture of goldfish cell sensitive to goldfish herpes virus 2003 ·Shanghai Shuichan Daxue xuebao ·Xiaoling Zhang	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact